Citation: Dg. Macgregor et al., PROTECTION BY AN ADENOSINE ANALOG AGAINST KAINATE-INDUCED EXTRAHIPPOCAMPAL NEUROPATHOLOGY, General pharmacology, 31(2), 1998, pp. 233-238
Citation: Dg. Macgregor et al., THE ATTENUATION OF KAINATE-INDUCED NEUROTOXICITY BY CHLORMETHIAZOLE AND ITS ENHANCEMENT BY DIZOCILPINE, MUSCIMOL, AND ADENOSINE RECEPTOR AGONISTS, Experimental neurology, 148(1), 1997, pp. 110-123
Authors:
MACGREGOR DG
HIGGINS MJ
JONES PA
MAXWELL WL
WATSON MW
GRAHAM DI
STONE TW
Citation: Dg. Macgregor et al., ASCORBATE ATTENUATES THE SYSTEMIC KAINATE-INDUCED NEUROTOXICITY IN THE RAT HIPPOCAMPUS, Brain research, 727(1-2), 1996, pp. 133-144
Authors:
MACGREGOR DG
JONES PA
MAXWELL WL
GRAHAM DI
STONE TW
Citation: Dg. Macgregor et al., PREVENTION BY A PURINE ANALOG OF KAINATE-INDUCED NEUROPATHOLOGY IN RAT HIPPOCAMPUS, Brain research, 725(1), 1996, pp. 115-120
Citation: Wj. Miller et al., TIME-COURSE OF PURINE PROTECTION AGAINST KAINATE-INDUCED INCREASE IN HIPPOCAMPAL [H-3] PK11195 BINDING, Brain research bulletin, 34(2), 1994, pp. 133-136
Citation: Dg. Macgregor et al., SYSTEMIC ASCORBATE PROTECTS AGAINST KAINATE NEUROTOXICITY, Biochemical Society transactions, 22(1), 1994, pp. 190000017-190000017
Citation: Dg. Macgregor et al., PERCEPTION OF RISKS FROM ELECTROMAGNETIC-FIELDS - A PSYCHOMETRIC EVALUATION OF A RISK-COMMUNICATION APPROACH, Risk analysis, 14(5), 1994, pp. 815-828
Citation: Dg. Macgregor et Tw. Stone, SYSTEMICALLY ADMINISTERED KAINATE NEUROTOXICITY CAN BE BLOCKED BY BOTH NMDA AND NON-NMDA ANTAGONISTS, British Journal of Pharmacology, 112, 1994, pp. 210000104-210000104
Citation: Dg. Macgregor et al., ASCORBATE OR ALLOPURINOL PROTECT AGAINST KAINATE-INDUCED NEUROTOXICITY, British Journal of Pharmacology, 112, 1994, pp. 210000143-210000143
Citation: Dg. Macgregor et Tw. Stone, BLOCKADE BY 2,3-DIPROPYL-8-CYCLOPENTYLXANTHINE (CPX) OF PURINE PROTECTION AGAINST KAINATE NEUROTOXICITY, Brain research, 644(2), 1994, pp. 339-342
Citation: Dg. Macgregor et al., MEDIATION OF THE NEUROPROTECTIVE ACTION OF R-PHENYLISOPROPYL-ADENOSINE THROUGH A CENTRALLY LOCATED ADENOSINE-A(1) RECEPTOR, British Journal of Pharmacology, 110(1), 1993, pp. 470-476
Citation: Dg. Macgregor et al., A CENTRALLY LOCATED ADENOSINE-A1-RECEPTOR PROTECTS AGAINST KAINIC ACID NEUROTOXICITY, British Journal of Pharmacology, 109, 1993, pp. 160000071-160000071
Citation: Dg. Macgregor et Tw. Stone, INHIBITION BY THE ADENOSINE ANALOG, (R-)-N(6)-PHENYLISOPROPYL-ADENOSINE, OF KAINIC ACID NEUROTOXICITY IN RAT HIPPOCAMPUS AFTER SYSTEMIC ADMINISTRATION, British Journal of Pharmacology, 109(2), 1993, pp. 316-321